Trial Outcomes & Findings for Almond Butter and Fasting Glucose (NCT NCT03826472)

NCT ID: NCT03826472

Last Updated: 2024-04-09

Results Overview

Fasting glucose measures how much glucose (sugar) is in a blood sample after an overnight fast. In this study, fasting glucose was measured by continuous glucose monitoring (interstitial glucose); fasting window identified through review of glucose monitoring data to be 4am-6am.

Recruitment status

COMPLETED

Study phase

PHASE2

Target enrollment

10 participants

Primary outcome timeframe

2 weeks

Results posted on

2024-04-09

Participant Flow

This was a crossover study, a total of 10 participants completed the study. Data from 1 participant was not used due a technology issue.

Participant milestones

Participant milestones
Measure
Almond Butter-No Snack Control
First intervention: Participants will consume one ounce per day (\~32 g) of almond butter as an evening snack (i.e., after dinner and before sleep). Almond Butter: Natural almond butter Second intervention: Participants will consume nothing besides water after dinner/bed sleep.
No-snack Control-Almond Butter
First intervention: Participants will consume nothing besides water after dinner/bed sleep. Second intervention: Participants will consume one ounce per day (\~32 g) of almond butter as an evening snack (i.e., after dinner and before sleep). Almond Butter: Natural almond butter
First Intervention (1-week)
STARTED
5
5
First Intervention (1-week)
COMPLETED
5
5
First Intervention (1-week)
NOT COMPLETED
0
0
Second Intervention (1-week)
STARTED
5
5
Second Intervention (1-week)
COMPLETED
5
5
Second Intervention (1-week)
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Almond Butter-No Snack
n=5 Participants
First intervention: Participants will consume one ounce per day (\~32 g) of almond butter as an evening snack (i.e., after dinner and before sleep). Almond Butter: Natural almond butter Second intervention: Participants will consume nothing besides water after dinner/bed sleep.
No Snack-Almond Butter
n=5 Participants
First intervention: Participants will consume nothing besides water after dinner/bed sleep. Second intervention: Participants will consume one ounce per day (\~32 g) of almond butter as an evening snack (i.e., after dinner and before sleep). Almond Butter: Natural almond butter
Total
n=10 Participants
Total of all reporting groups
Age, Continuous
59 years
n=5 Participants
58 years
n=5 Participants
58 years
n=10 Participants
Sex: Female, Male
Female
3 Participants
n=5 Participants
4 Participants
n=5 Participants
7 Participants
n=10 Participants
Sex: Female, Male
Male
2 Participants
n=5 Participants
1 Participants
n=5 Participants
3 Participants
n=10 Participants
Race and Ethnicity Not Collected
0 Participants
Race and Ethnicity were not collected from any participant.
Region of Enrollment
United States
5 Participants
n=5 Participants
5 Participants
n=5 Participants
10 Participants
n=10 Participants
Mean duration of diabetes
8.2 years
n=5 Participants
6.8 years
n=5 Participants
7.5 years
n=10 Participants
Home self-monitoring of blood glucose prior to study start
1 Participants
n=5 Participants
5 Participants
n=5 Participants
6 Participants
n=10 Participants
Medication use
3 participants
n=5 Participants
4 participants
n=5 Participants
7 participants
n=10 Participants

PRIMARY outcome

Timeframe: 2 weeks

Population: Adults with a diagnosis of type 2 diabetes, not on insulin therapy.

Fasting glucose measures how much glucose (sugar) is in a blood sample after an overnight fast. In this study, fasting glucose was measured by continuous glucose monitoring (interstitial glucose); fasting window identified through review of glucose monitoring data to be 4am-6am.

Outcome measures

Outcome measures
Measure
Almond Butter
n=9 Participants
Participants instructed to consume study provided 2 tbsp of natural almond butter after dinner and before bed.
No-snack Control
n=9 Participants
Participants asked not to consume any food or beverages besides water after dinner.
Fasting Glucose Measured Using Continuous Glucose Monitoring
148.6 mg/dL
Interval 94.9 to 202.3
142.1 mg/dL
Interval 94.0 to 190.3

SECONDARY outcome

Timeframe: 2 weeks

Population: 9 participants total; 9 analyzed in each group (crossover study)

Overnight (12pm-4am) mean blood sugar values measured by continuous glucose monitoring (interstitial glucose)

Outcome measures

Outcome measures
Measure
Almond Butter
n=9 Participants
Participants instructed to consume study provided 2 tbsp of natural almond butter after dinner and before bed.
No-snack Control
n=9 Participants
Participants asked not to consume any food or beverages besides water after dinner.
Glucose Trends
147.7 mg/dL
Interval 92.6 to 202.8
142.2 mg/dL
Interval 91.8 to 191.0

SECONDARY outcome

Timeframe: 2 weeks

Population: 9 participants total; 9 analyzed in each group (crossover study)

Go-NoGo task asked participants to press a button when a letter other than X was on screen and not press a button when X was present.

Outcome measures

Outcome measures
Measure
Almond Butter
n=9 Participants
Participants instructed to consume study provided 2 tbsp of natural almond butter after dinner and before bed.
No-snack Control
n=9 Participants
Participants asked not to consume any food or beverages besides water after dinner.
Inhibitory Control Task (Percent Correct)
35.34 percentage correct
Standard Deviation 1.51
35.51 percentage correct
Standard Deviation 1.98

Adverse Events

Almond Butter

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

No-snack Control

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Emily Johnston

California Health Sciences University College of Osteopathic Medicine

Phone: 9737685888

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place